Initiator Pharma A/S (STO:INIT)

Initiator Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.37	24.34	39.11	34.35	13.5
Cash & Short-Term Investments	13.37	24.34	39.11	34.35	13.5
Cash Growth	-45.06%	-37.78%	13.88%	154.34%	78.58%
Other Receivables	1.9	5.43	7.21	4.13	2.03
Receivables	1.9	5.43	7.21	4.13	2.03
Prepaid Expenses	-	-	2.01	15.23	-
Other Current Assets	-	-	-	-	0.06
Total Current Assets	15.28	29.77	48.33	53.7	15.59
Other Intangible Assets	-	-	-	-	0.01
Other Long-Term Assets	0.02	0.02	0.02	-	-
Total Assets	15.29	29.79	48.35	53.7	15.6
Accounts Payable	0.37	0.41	0.8	4.8	0.67
Accrued Expenses	0.49	2.53	-	-	-
Other Current Liabilities	-0.34	0.25	0.94	0.62	0.53
Total Current Liabilities	0.51	3.19	1.75	5.42	1.19
Long-Term Debt	-	15.44	12.58	13.29	-
Total Liabilities	0.51	18.62	14.32	18.71	1.19
Common Stock	5.9	5.51	5.5	4.6	2.91
Retained Earnings	8.89	5.65	28.53	30.4	11.5
Shareholders' Equity	14.78	11.16	34.02	34.99	14.41
Total Liabilities & Equity	15.29	29.79	48.35	53.7	15.6
Total Debt	-	15.44	12.58	13.29	-
Net Cash (Debt)	13.37	8.9	26.54	21.06	13.5
Net Cash Growth	50.25%	-66.46%	26.02%	55.92%	78.58%
Net Cash Per Share	0.23	0.16	0.50	0.60	0.49
Filing Date Shares Outstanding	56.16	52.47	52.36	43.77	27.71
Total Common Shares Outstanding	56.16	52.47	52.36	43.77	27.71
Working Capital	14.77	26.58	46.58	48.28	14.4
Book Value Per Share	0.26	0.21	0.65	0.80	0.52
Tangible Book Value	14.78	11.16	34.02	34.99	14.4
Tangible Book Value Per Share	0.26	0.21	0.65	0.80	0.52

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.